Transgene Biotek Limited · Valuation · TradingHolo

Transgene Biotek Limited · Valuation · TradingHolo

Multiples

Shown only where the company is comparable with its peers

Multiple	Now	Sector median	Where it sits
P/E	−9.9×	27.7×
Price / Book	2.0×	3.1×
Price / Sales	77.5×	3.0×
Price / Free cash flow	−5.5×	0.9×
EV / EBITDA	−61.6×	17.2×
Earnings yield	−10.1%	2.4%
Free cash flow yield	−18.3%	0.0%	—

P/E at each quarterly report

Price at the report date ÷ trailing twelve-month earnings

No comparable valuation history is available.

Peers

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
NSE:SUNPHARMASun Pharmaceuticals Industries Ltd · 🇮🇳 NSE	₹1,739.60	−0.20%	$43.96B	36.5×	13.7%	+2.6%
NSE:DIVISLABDivi's Laboratories Ltd · 🇮🇳 NSE	₹9,119.50	+0.36%	$25.48B	94.0×	15.3%	+37.8%
NSE:TORNTPHARMTorrent Pharmaceuticals Ltd · 🇮🇳 NSE	₹4,517.50	−0.90%	$18.04B	80.0×	25.8%	+27.3%
NSE:LAURUSLABSLaurus Labs Ltd · 🇮🇳 NSE	₹2,037.60	−1.52%	$11.55B	125.4×	16.8%	+121.4%
NSE:ZYDUSLIFEZydus Lifesciences Ltd · 🇮🇳 NSE	₹1,113.30	−0.05%	$11.67B	22.0×	18.6%	+10.8%
NSE:APOLLOHOSPApollo Hospitals Enterprise Ltd · 🇮🇳 NSE	₹7,653.00	−0.61%	$11.58B	57.0×	20.5%	−1.8%
NSE:CIPLACipla Ltd · 🇮🇳 NSE	₹1,320.20	−0.29%	$11.28B	27.7×	11.3%	−16.4%
NSE:DRREDDYDr Reddy's Laboratories Ltd · 🇮🇳 NSE	₹1,243.60	+0.09%	$10.91B	24.2×	11.4%	−2.9%
NSE:MANKINDMankind Pharma Ltd · 🇮🇳 NSE	₹2,250.90	−0.10%	$9.78B	48.6×	11.7%	−7.9%
NSE:AUROPHARMAAurobindo Pharma Ltd · 🇮🇳 NSE	₹1,600.60	−1.28%	$9.65B	26.5×	9.2%	+47.3%